These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 32202061)
21. Case-control study of second-line therapies for type 2 diabetes in combination with metformin and the comparative risks of myocardial infarction and stroke. Floyd JS; Wiggins KL; Sitlani CM; Flory JH; Dublin S; Smith NL; Heckbert SR; Psaty BM Diabetes Obes Metab; 2015 Dec; 17(12):1194-7. PubMed ID: 26179389 [TBL] [Abstract][Full Text] [Related]
22. Relapsed 6q24-related transient neonatal diabetes mellitus successfully treated with sulfonylurea. Fu JL; Wang T; Xiao XH Chin Med J (Engl); 2019 Apr; 132(7):846-848. PubMed ID: 30897598 [No Abstract] [Full Text] [Related]
23. [Effect of sulfanilamide preparations on the blood coagulation system in patients with diabetes mellitus]. Vasiukova EA; Pisarskaia IV; Sharova IuA Ter Arkh; 1974; 46(10):53-5. PubMed ID: 4432223 [No Abstract] [Full Text] [Related]
35. The role of hypoglycemic sulphonylureas in arrhythmias contributing to the mortality in acute myocardial ischemia. Koltai MZ; Aranyi Z; Ballagi-Podány G; Pogátsa G Acta Physiol Hung; 1990; 75 Suppl():175-6. PubMed ID: 2371854 [No Abstract] [Full Text] [Related]
37. Possible risk of sulphonylureas in the treatment of non-insulin-dependent diabetes mellitus and coronary artery disease. Fasching P Diabetologia; 1998 Jun; 41(6):743-4. PubMed ID: 9662063 [No Abstract] [Full Text] [Related]
38. Cardiovascular safety of DPP-4 inhibitors compared with sulphonylureas: Results of randomized controlled trials and observational studies. Scheen AJ Diabetes Metab; 2018 Nov; 44(5):386-392. PubMed ID: 30126735 [TBL] [Abstract][Full Text] [Related]
39. Diabetes and coronary artery disease: time to stop taking the tablets. Edwards RJ; Rakhit RD; Marber MS Heart; 1999 Jun; 81(6):674. PubMed ID: 10979714 [No Abstract] [Full Text] [Related]
40. Effects on Clinical Outcomes of Adding Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas to Metformin Therapy in Patients With Type 2 Diabetes Mellitus. Ou SM; Shih CJ; Chao PW; Chu H; Kuo SC; Lee YJ; Wang SJ; Yang CY; Lin CC; Chen TJ; Tarng DC; Li SY; Chen YT Ann Intern Med; 2015 Nov; 163(9):663-72. PubMed ID: 26457538 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]